Brief: Doma Perpetual Capital Management Asserts Pacira Biosciences's Board To Pursue Sale Of Company
30/12/2025 15:45
Dec 30 (Reuters) - DOMA PERPETUAL CAPITAL MANAGEMENT: DOMA PERPETUAL CAPITAL MANAGEMENT ANNOUNCES INTENT TO NOMINATE THREE HIGHLY QUALIFIED, INDEPENDENT DIRECTOR CANDIDATES AT 2026 ANNUAL MEETING OF PACIRA BIOSCIENCES, INC. DOMA PERPETUAL CAPITAL MANAGEMENT: ASSERTS PACIRA BIOSCIENCES'S BOARD OF DIRECTORS SHOULD PURSUE AN IMMEDIATE SALE OF COMPANY
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal